AZELIS GROUP N.V./ BE0974400328 /
29/05/2024 21:44:06 | Var. -0.080 | Volume | Denaro21:55:07 | Lettera21:55:07 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
19.160EUR | -0.42% | 50 Fatturato: 965 |
19.010Quantità in denaro: 100 | 19.230Quantità in lettera: 100 | 4.65 bill.EUR | 1.15% | 25.81 |
GlobeNewswire
23:03
Kessler Topaz Meltzer & Check, LLP Reminds Inari Medical, Inc. Investors of Important Deadline in Se...
GlobeNewswire
23:01
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agrify Corp...
Newsfile Corp
23:01
IAMGOLD annonce les résultats de l'assemblée générale et extraordinaire annuelle des actionnaires
GlobeNewswire
23:00
Lilium Announces Successful Arrangement of $114 Million Capital Raise With Participation From Strate...
GlobeNewswire
22:56
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avangrid, I...
GlobeNewswire
22:46
Biogen Inc. (Nasdaq: BIIB) Investors Notice: Class action lawsuit filed on behalf of investors; the ...
GlobeNewswire
22:45
Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
22:43
Li Auto Inc. (LI) Investors: July 9, 2024 Filing Deadline in Securities Class Action - Contact Kessl...
GlobeNewswire
22:30
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
GlobeNewswire
22:30
X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinica...